Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05629520 · ClinicalTrials.gov registry record
A Neurobiological Model of Anhedonia
A clinical trial, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- 60
- Enrollment target
NCT05629520: Completed study, sponsored by Milton S. Hershey Medical Center.
NCT05629520 is a clinical trial that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05629520 has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The purpose of this research study is to better understand anhedonia in Major Depressive Disorder by investigating the reward-related neural and inflammatory correlates.
Primary Outcome
Quantify the profile of basal inflammatory markers (IL-6 and C-reactive protein) in blood. Blood will be collected within an hour after consent and will be processed by 3 hours.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2020-02-19 |
| Est. Completion | 2024-07-30 |
What the finished NCT05629520 record still lists
NCT05629520 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05629520 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05629520 about?
NCT05629520 is a clinical study titled "A Neurobiological Model of Anhedonia". The purpose of this research study is to better understand anhedonia in Major Depressive Disorder by investigating the reward-related neural and inflammatory correlates.
What is the current status of trial NCT05629520?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2020-02-19. Estimated completion is 2024-07-30.
Who is sponsoring clinical trial NCT05629520?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI